Ledger.Open graph →
SEC Form D · filed January 31, 2024

Amytrx Therapeutics, Inc

Offering
$6.0M
Sold
$725K
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
NASHVILLE, TN
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Matthew Gonda · NASHVILLE, TNDirectorLawrence Greer · Nashville, TNDirectorSatish Joshi · Nashville, TNDirectorMichael Howell · Seattle, WADirectorDennis Carlo · NASHVILLE, TNDirectorRaymond Pirtle · Nashville, TNDirectorMatthew Gonda · NASHVILLE, TNDirectorLawrence Greer · Nashville, TNDirectorSatish Joshi · Nashville, TNDirectorMichael Howell · Seattle, WADirectorDennis Carlo · NASHVILLE, TNDirectorRaymond Pirtle · Nashville, TNDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗